Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Nephrology/Urology
Disease Category: Renal Cell Carcinoma
Trial Information
Study for high risk recurrence of renal cell carcinoma after surgical treatment
A Multicenter, Randomized Phase III Study of Adjuvant Oncophage®
Versus Observation in Patients with High Risk of Recurrence After
Surgical Treatment for Renal Cell Carcinoma.
You may be eligible to participate in this research study if
you:
- Are 18 years of age or older
- Have renal cell cancer that can be surgically removed
You are not eligible to participate in this research study if
you:
- Received prior chemotherapy, hormone therapy, immunotherapy, or
radiotherapy for your renal cell cancer
- Are using immunosuppressive drugs
- Have current malignancies at other sites or previous other
cancer within the last 5 years
- Have known distant metastases
- Have an active, uncontrolled infection or other serious medical
illness that requires hospitalization
Mary-Jane Keister, Research Coordinator
Biomedical Research Alliance of New York, LLC
535 Plandome Road, Suite 3
Manhasset, NY 11030
Phone: 516-365-4631 ext. 195
Fax: 516-869-0086
EMail: uamedresearch@aol.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
